Droplet / Contact Precautions
Respiratory Syncitial Virus
Empiric antiviral therapy generally not recommended
Inhaled ribavirin may be used in selected cases (i.e. immunocompromised patient with severe disease); requires ID consult
RSV Prophylaxis for publicly-funded Palivizumab requires enrollment into the RSV Program. More information can be found here
Contact the SickKids RSV Program at [email protected] for more information.